Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells

Kelly Airiau(Université de Bordeaux), François‐Xavier Mahon(Hammersmith Hospital)

Oncotarget

November 27, 2015

10.18632/oncotarget.6417

Cited by 21

Related Papers

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

|Blood|2006|604

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models

|Blood|2003|538

PI3K/mTOR pathway inhibitors sensitize chronic myeloid leukemia stem cells to nilotinib and restore the response of progenitors to nilotinib in the presence of stem cell factor

|Cell Death and Disease|2013|67

TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex

|Cells|2021|9